Data / Form D filings / Invirsa, Inc.
Invirsa, Inc.: Form D filings
Invirsa, Inc., a pharmaceuticals company in Columbus, OH, filed 5 Form D notices with the SEC between 2020 and 2025. The latest, on August 8, 2025, reports $2.9 million sold of a $2.9 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1275 KINNEAR ROAD, Columbus, OH, 43212
- Phone
- (614) 715-1860
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1836108
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Amendment | $2,860,000 | $2,860,000 | 14 | Jul 22, 2025 | sec.gov | |
| Aug 6, 2025 | New notice | $2,832,000 | $2,832,000 | 14 | Jul 22, 2025 | sec.gov | |
| Nov 29, 2023 | New notice | $999,998 | $999,998 | 1 | Nov 14, 2023 | sec.gov | |
| Dec 29, 2022 | New notice | $7,700,000 | $5,976,217 | $1,723,783 | 8 | Dec 21, 2022 | sec.gov |
| Dec 11, 2020 | New notice | $40,245 | $40,245 | 1 | Nov 12, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rachael Wingo | Executive Officer | |
| Wayne Embree | Director | |
| Tim Willis | Director | |
| Robert Shalwitz | Executive Officer, Director | |
| Faith Voinovich | Director |
Other pharmaceuticals companies in Ohio that filed recently
- EIKONOKLASTES THERAPEUTICS, INC. $16.1 million · Oct 6, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in Ohio · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Invirsa, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.